These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 18464924)

  • 21. Activity of florfenicol for Actinobacillus pleuropneumoniae and Pasteurella multocida using standardised versus non-standardised methodology.
    Dorey L; Hobson S; Lees P
    Vet J; 2016 Dec; 218():65-70. PubMed ID: 27938711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo antimicrobial activity of marbofloxacin against Pasteurella multocida in a tissue cage model in calves.
    Cao C; Qu Y; Sun M; Qiu Z; Huang X; Huai B; Lu Y; Zeng Z
    Front Microbiol; 2015; 6():759. PubMed ID: 26257726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Homology modeling, functional annotation and comparative genomics of outer membrane protein H of Pasteurella multocida.
    Ganguly B; Tewari K; Singh R
    J Theor Biol; 2015 Dec; 386():18-24. PubMed ID: 26362105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potency of marbofloxacin for pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida: Comparison of growth media.
    Dorey L; Hobson S; Lees P
    Res Vet Sci; 2017 Apr; 111():43-48. PubMed ID: 27940285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emergence of a multidrug-resistant hypervirulent Pasteurella multocida ST342 strain with a floR-carrying plasmid.
    Zhu D; Yuan D; Wang M; Jia R; Chen S; Liu M; Zhao X; Yang Q; Wu Y; Zhang S; Huang J; Liu Y; Zhang L; Yu Y; Pan L; Chen X; Cheng A
    J Glob Antimicrob Resist; 2020 Mar; 20():348-350. PubMed ID: 31557567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetic/pharmacodynamic integration of cefquinome against Pasteurella Multocida in a piglet tissue cage model.
    Zhang L; Wu X; Huang Z; Kang Z; Chen Y; Shen X; Cai Q; Ding H
    J Vet Pharmacol Ther; 2019 Jan; 42(1):60-66. PubMed ID: 30407642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrated pharmacokinetic-Pharmacodynamic (PK/PD) model to evaluate the in vivo antimicrobial activity of Marbofloxacin against Pasteurella multocida in piglets.
    Zeng QL; Mei X; Su J; Li XH; Xiong WG; Lu Y; Zeng ZL
    BMC Vet Res; 2017 Jun; 13(1):178. PubMed ID: 28619095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experimental pathogenicity and complete genome characterization of a pig origin Pasteurella multocida serogroup F isolate HN07.
    Peng Z; Liang W; Wang Y; Liu W; Zhang H; Yu T; Zhang A; Chen H; Wu B
    Vet Microbiol; 2017 Jan; 198():23-33. PubMed ID: 28062004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Bactericidal activity of ciprofloxacin and sparfloxacin. Comparison with others active antibiotics against Pasteurella multocida].
    Gastine C; Donnio PY; Travert MF; Avril JL
    Presse Med; 1995 Mar; 24(11):519-22. PubMed ID: 7770389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genome characterization of Pasteurella multocida subspecies septica and comparison with Pasteurella multocida subspecies multocida and gallicida.
    Peng Z; Liang W; Liu W; Chen H; Wu B
    Arch Microbiol; 2017 May; 199(4):635-640. PubMed ID: 28175928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibiotic susceptibilities of human isolates of Pasteurella multocida.
    Stevens DL; Higbee JW; Oberhofer TR; Everett ED
    Antimicrob Agents Chemother; 1979 Sep; 16(3):322-4. PubMed ID: 507787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic-pharmacodynamic integration and modelling of oxytetracycline for the calf pathogens Mannheimia haemolytica and Pasteurella multocida.
    Lees P; Potter T; Pelligand L; Toutain PL
    J Vet Pharmacol Ther; 2018 Feb; 41(1):28-38. PubMed ID: 28736817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship of in vitro minimum inhibitory concentrations of tilmicosin against Mannheimia haemolytica and Pasteurella multocida and in vivo tilmicosin treatment outcome among calves with signs of bovine respiratory disease.
    McClary DG; Loneragan GH; Shryock TR; Carter BL; Guthrie CA; Corbin MJ; Mechor GD
    J Am Vet Med Assoc; 2011 Jul; 239(1):129-35. PubMed ID: 21718206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of marbofloxacin dosage for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida by pharmacokinetic/pharmacodynamic modelling.
    Dorey L; Pelligand L; Lees P
    BMC Vet Res; 2017 Jul; 13(1):209. PubMed ID: 28666426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genome-Wide Differential Expression Profiling of Pulmonary circRNAs Associated With Immune Reaction to
    Chen Q; Zhang Z; Chen S; Chen J; Cheng Y; Liu A; Li B; Chen Z; Zheng Y; Ga M; Du L; Wang F
    Front Vet Sci; 2021; 8():615405. PubMed ID: 34235193
    [No Abstract]   [Full Text] [Related]  

  • 36. How does Pasteurella multocida respond to the host environment?
    Boyce JD; Adler B
    Curr Opin Microbiol; 2006 Feb; 9(1):117-22. PubMed ID: 16406771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of envelope proteins from Pasteurella haemolytica and Pasteurella multocida.
    Knights JM; Adlam C; Owen P
    J Gen Microbiol; 1990 Mar; 136(3):495-505. PubMed ID: 2391489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimicrobial susceptibility and resistance of chicken Escherichia coli, Salmonella spp., and Pasteurella multocida isolates.
    Huang TM; Lin TL; Wu CC
    Avian Dis; 2009 Mar; 53(1):89-93. PubMed ID: 19432009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathogenomics of Pasteurella multocida.
    Boyce JD; Seemann T; Adler B; Harper M
    Curr Top Microbiol Immunol; 2012; 361():23-38. PubMed ID: 22402726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A ten-year (2000-2009) study of antimicrobial susceptibility of bacteria that cause bovine respiratory disease complex--Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni--in the United States and Canada.
    Portis E; Lindeman C; Johansen L; Stoltman G
    J Vet Diagn Invest; 2012 Sep; 24(5):932-44. PubMed ID: 22914822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.